Stockholm, March 22nd, 2016
Anita Tollstadius, CEO and primary insider in ContextVision AB, has between March 21st and March 22nd 2016 purchased 2 000 shares in ContextVision AB at an average price of NOK 32,45 per share.
Following this transaction, Anita Tollstadius owns 7 000 shares in ContextVision AB. Anita Tollstadius also owns 10 000 shares through her 100% owned company Tollstadius & Co AB.
ContextVision’s cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, the company’s state-of-the-art medical image analysis and enhancement software for 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography is used by leading equipment manufacturers worldwide. ContextVision continues to invest heavily in R&D in order to expand its technology platform. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.